rediff.com
e.g. Tata motors, Reliance MF, 500570
Shukra Pharmaceuticals Ltd. - Research Center
524632 SHUKRAPHAR Group (X) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Sources of funds
Owner's fund
Equity share capital 10.95 3.91 1.57 1.57 1.57
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 46.69 21.38 14.78 14.03 13.85
Loan funds
Secured loans 0.50 1.31 0.25 - -
Unsecured loans 2.66 3.77 3.13 9.77 8.05
Total 60.79 30.38 19.73 25.37 23.46
Uses of funds
Fixed assets
Gross block 41.33 41.22 35.08 17.69 33.40
Less : revaluation reserve - - - - -
Less : accumulated depreciation 21.38 20.99 17.50 - 16.02
Net block 19.94 20.23 17.58 17.69 17.38
Capital work-in-progress 1.66 1.66 1.66 1.66 1.66
Investments - - 0.20 0.19 0.05
Net current assets
Current assets, loans & advances 56.23 53.07 15.67 15.22 14.45
Less : current liabilities & provisions 17.04 44.59 15.39 9.39 10.08
Total net current assets 39.19 8.48 0.28 5.82 4.37
Miscellaneous expenses not written - - - - -
Total 60.79 30.38 19.73 25.37 23.46
Notes:
Book value of unquoted investments - - 0.20 0.19 0.05
Market value of quoted investments - - - - -
Contingent liabilities 1.40 1.40 - - -
Number of equity sharesoutstanding (Lacs) 109.51 109.60 15.66 15.66 15.66
Close
Add Shukra Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Shukra Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close